Trial Profile
A reterospective study of Romiplostim in patients with Immune Thrombocytopenic Purpura (ITP): The United Kingdom Immune Thrombocytopenia (UKITP) registry study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Sep 2016
Price :
$35
*
At a glance
- Drugs Romiplostim (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 14 Sep 2016 New trial record